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Background: Medical abortion in the United States requires clinic-based follow-up, representing additional time and cost to women and
clinics. We studied a semi-quantitative home pregnancy test as a possible replacement for in-person follow-up.
Study Design: Four hundred and ninety women participated in the clinical study and used a pregnancy test to determine baseline human
chorionic gonadotropin (hCG) on the day of mifepristone administration and follow-up hCG 1 week later. One hundred and eighty-nine other
women completed a user comprehension survey. Accuracy, feasibility and acceptability of the test were assessed in both the clinical study
and the survey.
Results: The test identified the one ongoing pregnancy in the clinical study cohort. Sensitivity and specificity were calculated at 100.0% and
97.0%. Themajority of participants in both the clinical study and the user comprehension survey found the test to be “very easy” or “easy” to use.
Conclusion: At-home follow-up with a semi-quantitative pregnancy test is feasible for service delivery in the United States.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Keywords: Medical abortion; Semi-quantitative pregnancy test; Human chorionic gonadotropin (hCG)1. Introduction
Current clinical practice in US health care facilities
requires women to return for clinic-based follow-up care
after medical abortion. This visit is used primarily to
determine if the abortion was successful and typically
includes a pelvic exam and a combination of pregnancy
testing and/or ultrasonography. However, the visit adds
additional time and cost burdens to women seeking abortion
services and clinics. Because of the high success rate of the
method, several studies have explored alternate methods of
follow-up that would eliminate the need for in-person
assessment for all but a small number of women [1–3].
These alternative methods include home pregnancy tests,☆ This study was funded by an anonymous donor.
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Open access under CC BY-NC-ND license.standardized questionnaires and/or phone- or Internet-based
clinician interactions.
Our study focused on the home pregnancy test as a
possible replacement for in-person follow-up. Previous
studies have shown that serum human chorionic gonadotro-
pin (hCG) measures can determine successful pregnancy
termination in medical abortion without the use of
sonography [1,2]. Since hCG can also be measured using
urine pregnancy tests, an accurate (and easy to interpret)
urine test combined with a clinician phone consultation
could allow women at home to evaluate their abortion
outcomes and return to the clinic only if further attention
were warranted [2,4].
To that end, two earlier studies examined the potential of
at-home follow-up with urine pregnancy tests. Grossman
et al. [5] explored whether urine hCG levels corresponded to
serum hCG. Of the 97 women enrolled, there were 5 false
negatives, representing women whose urine pregnancy test
identified them as having clinically lower hCG levels than
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specificity of the urine test to determine a serum level above
1000 mIU/mL was 88.6% and 71.7%, respectively. A second
study, by Godfrey et al. [6], examined the correlation of
urine hCG testing to serum hCG levels using both low- and
high-sensitivity urine pregnancy tests and found that low-
sensitivity tests are effective in determining false negatives
and could reduce some clinic-based follow-up, but that the
high rate of false-positive results would still lead to
additional (and possibly unnecessary) testing and/or pro-
cedures at follow-up.
In the present studies, we explored the feasibility and
acceptability of an at-home semi-quantitative hCG in lieu
of clinic-based follow-up 1 week after mifepristone
administration. We sought to determine how well the test
predicted completion of abortion and to what extent
women at home could use it to correctly interpret the
results. We hypothesized that if the semi-quantitative
pregnancy test could estimate hCG levels with enough
accuracy to identify ongoing pregnancy, it could simplify
medical abortion care globally.ig. 1. Images of semi-quantitative pregnancy test used in these studies with
ading of 2000 mIU/mL hCG. C: control line. A control line indicates that
e test strip has been properly saturated with urine. A control line must
ppear in all five columns for the test to be considered valid. T: test line. A
st line indicates a positive test result. A column with one line (a C line but
ot a T line) is indicative of a negative test reading. A column consisting of
o lines (a C line and a T line) indicates a positive test reading for the
pecific level of hCG.2. Materials and methods
This clinical study was a 1-year open-label trial.
Women presenting for medical abortion at one of the four
sites (Stanford University Hospital's OB/GYN clinic, Palo
Alto, CA; Planned Parenthood Mar Monte, Sacramento,
CA; and two clinics of the Family Planning Associates
Medical Group, Limited, Chicago, IL, USA) were invited
to join the study. Eligibility for participating women
included being 18 years or older, having a pregnancy
with gestational age of ≤63 days by last menstrual period
using ultrasound or clinical assessment, agreeing to return
for a follow-up visit, providing an address and/or
telephone number for follow-up and being able to consent
to study participation. All sites received institutional
review board approval to conduct this research, and all
participants gave written informed consent.
Study participants were asked to take a semi-quantitative
pregnancy test on the day of mifepristone administration to
serve as a baseline. Each woman was given one semi-
quantitative urine pregnancy test and a sample collection
cup to take home. Either first-morning or random urine
could be used as an earlier study determined no difference
in hCG reading using samples from either time of day
(Blumenthal P., personal communication). Women were
scheduled to return for a follow-up visit 1 week later.
Women were also given written instructions explaining how
to use the test and a short questionnaire to complete after
using the test at home.
The morning of the follow-up visit, each woman collected
a small amount of her urine in the cup which she then used to
perform the pregnancy test. Participants were instructed to
bring the completed questionnaire and pregnancy test to thefollow-up visit. Upon arrival at the clinic, the woman was
interviewed about her pregnancy status. A health provider
recorded the woman's assessment of her pregnancy status
and then completed further assessments using standard
clinical means (including any of the following: a physical
exam, ultrasound and/or serum hCG); the provider then
reviewed the semi-quantitative test result and questionnaire
with the woman. The provider used this information to
determine the outcome of her abortion. If the health provider
found that urine plus clinical testing results were inconclusive
or contradictory, the provider conducted a serum hCG
measurement at this time. All other standard care for early
medical abortion was offered to women as per procedures at
each health center.
The clinical study used the dBest® (AmeriTek Inc.,
Everett, WA, USA) semi-quantitative panel test. The dBest
panel test is a one-step immunochromatographic assay to
detect hCG in urine with cutoffs of 25, 100, 500, 2000 and
10,000 mIU/mL (Fig. 1). Tests were provided to participants
free of charge for use in the study. In normal pregnancies,
hCG levels will double every 48–72 h, peaking at 8–11
weeks of pregnancy and then declining for the remainder of
the pregnancy. Levels should decrease substantially follow-
ing a completed abortion [7]. In this study, a pregnancy was
considered ongoing if the follow-up hCG reading was the
same or higher than the baseline result.
At the same time, we conducted a user comprehension
survey to assess women's ability to read and interpret theF
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Table 1
Clinical trial participant characteristics
n=490
Age, in years: mean±SD (range) 26±6 (18–45)
Education completed: % (n)
Did not finish HS/receive GED 9.5 (45/473)
High school or GED 49.7 (235/473)
College degree 32.4 (153/473)
Postgraduate degree 8.5 (40/473)
Gestational age, in days: mean±SD (range)a 46±7 (33–63)
Participant still thought she was pregnant (or was unsure)
prior to taking at-home test: % (n)b
15.8 (55/348)
Participant had complete medical abortion 92.7 (51/55)
Participant had surgical intervention 7.3 (4/55)
a n=487.
b Data not included for 96 women who were lost to follow-up and 45
women for whom data are not available.
able 2
utcomes of medical abortion among clinical trial participants: % (n)
n=394
edical abortion outcome, all participants: % (n)a
Success 97.5 (384)
Surgical intervention 2.5 (10)
Persistent nonviable pregnancy or sac 2.0 (8)
Retained products of conception 0.3 (1)
Ongoing pregnancy 0.3 (1)
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the four locations (all but Stanford University Hospital), who
were not participating in the clinical study and were age 18
years or older, were asked to complete the survey. Using a
closed box to randomly draw from, participants completed a
questionnaire containing an instruction sheet and a selection
of pictorial renderings showing a variety of semi-quantitative
pregnancy test results. Survey respondents gave informed
consent and received a $10 Starbucks gift card.MIFEPRISTONE ADMINISTERED 
BASELINE PREGNANY TEST DONE 
(n=490) 
MISOPROSTOL ADMINISTERED AT HOME 
(n=490) 
ONE WEEK FOLLOW-UP AT CLINIC (n=394) 
Lost to follow-up (n=96) 
ANALYSED WITH ALL DATA AVAILABLE (N=394) 
ANALYSED, NO PREGNANCY TEST DATA (N=327) 
Pregnancy test data not available or inconclusive result (n=67) 
SCREENED & ENROLLED (n= 490) 
Fig. 2. Flow of clinical trial participants.Data from both the clinical study and the user
comprehension survey were entered into SPSS (Version
15, Chicago, IL, USA). All analyses were conducted using
STATA (version 11, College Station, TX, USA). Results are
presented as frequencies and means.3. Results
Between February 2010 and March 2011, 490 women
enrolled in the clinical study. The average age of participants
was 26 years, and approximately two fifths of them (40.9%)
had completed a college degree (153/473) or higher
education (40/473) (Table 1). The mean gestational age of
their pregnancies was 46 days. Unfortunately, one fifth of
participants (19.6%, n=96) did not return for follow-up andedical abortion outcome among women whose
at-home pregnancy test signaled need for clinic-based
follow-up: % (n)
n=10
No intervention needed 90.0 (9/10)
Persistent nonviable pregnancy or sac 10.0 (1/10)
Retained products of conception 0.0 (0)
Ongoing pregnancyb 0.0 (0)
edical abortion outcome for women receiving
additional interventions at follow-up not signaled
by at-home pregnancy testc
n=6
Persistent nonviable pregnancy or sac, had
at-home tests
100.0 (6)
Retained products of conception 0.0 (0)
Ongoing pregnancy 0.0 (0)
articipant correctly understood whether or not the
at-home pregnancy test result signaled need for
clinic-based follow-up: % (n)d
58.1 (190/327)
ase of using at-home test (n=349e)
Very easy/easy 91.1 (316/347)
Neither easy nor difficult 6.9 (24/347)
Difficult/very difficult 2.0 (7/347)
rovider's explanation helped in test use and
comprehension (n=349e)
Yes 89.5 (306/342)
No 4.7 (16/342)
Don't know 5.8 (20/342)
a Data do not include 96 participants who were lost to follow-up.
b The one woman with the ongoing pregnancy did not use the pregnancy
st at home; therefore, the ongoing pregnancy was not identified at home.
he woman did use the test at the clinic at follow-up, and the test identified
e ongoing pregnancy.
c Three other women receiving surgical intervention did not complete
t-home pregnancy test.
d Data do not include 67 women for whom data were not available or
ome test was inconclusive.
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Does not include 45 women for whom data were not available.
Table 3
Sensitivity/specificity and positive/negative predictive values of semi-
quantitative pregnancy test based on clinical trial client's readinga of semi-
quantitative pregnancy test: % (n) b,c
Ongoing
pregnancy
All other
outcomes
RR (95% CI)
Test indicated steady or
increasing hCG
(n=11/331)
100.0 (1/1)b 3.0 (10/331) 34.6 (18.8–63.8)
Test indicated decreasing
hCG (n=321/331)
0.0 (0/1) 97.0 (321/331)
Sensitivity: 100.0%; specificity: 97.0%
Positive predictive value: 9.1%; negative predictive value: 100.0%
a Client's reading is not available for 60 clients with complete abortion,
1 client with retained products of conception and 1 client with persistent
nonviable pregnancy or sac.
b The one woman with the ongoing pregnancy did not use the pregnancy
test at home; therefore, the ongoing pregnancy was not identified at home.
The woman did use the test at the clinic at follow-up, and the test identified
the ongoing pregnancy.
c Analysis based on client reading of test compared to clinician
assessment of abortion status on day of follow-up.
able 4
esults of user comprehension surveya
n=189
ge, in years: mean±SD (range)b 27±6 (18–54)
ducation completed: % (n)
Did not finish HS/receive GED 6.2 (10/161)
High school or GED 64.0 (103/161)
College degree 28.0 (45/161)
Postgraduate degree 1.9 (3/161)
regnancy test was matched with correct
corresponding image: % (n)
92.1 (174/189)
Among women with less than college degree 88.5 (100/113)
Among women with college degree or higher 100.0 (48/48)
nderstood numerical value of test: % (n) 73.6 (128/174)
Among women with less than college degree 66.0 (66/100)
Among women with college degree or higher 85.4 (41/48)
struction sheet helped with interpreting
pregnancy test results: % (n)
77.2 (132/171)
est was easy to use: % (n)
Very easy/easy 59.3 (112/189)
Neither easy nor difficult 28.6 (54/189)
Difficult/very difficult 12.2 (23/189)
oman believes she could use test on her own in the
future to determine pregnancy status: % (n)
80.7 (138/171)
Among women with less than college degree 79.2 (80/101)
Among women with college degree or higher 82.6 (38/46)
a Participants in the user comprehension survey represent a different
atient population. These respondents did not participate in the clinical trial.
b n=188.
760 J. Blum et al. / Contraception 86 (2012) 757–762could not be located. Thus, data from 394 women were
available for evaluation. Fig. 2 shows the flow of clinical
trial participants.
Prior to taking the home pregnancy test, women were
asked to note on their home questionnaire whether or not
they felt that their abortion was now complete. Around one
sixth of participants (n=55) were not sure or thought they
were still pregnant. Of these women, 51 had a complete
abortion, while 4 received a surgical intervention. Of the
women for whom outcome data are available (n=394), the
vast majority (97.5%, n=384) had successful abortions,
which we defined as an abortion completed without surgical
intervention (Table 2).
Ten women had an at-home pregnancy test that signaled
the need for clinic-based follow-up as the test showed the
same or an increase in hCG compared to baseline (Table 2).
Of these, eight women who had no change in hCG, and one
who had an increase in hCG required no additional
interventions. One additional woman had no change in
hCG and was diagnosed with a persistent nonviable
pregnancy/sac that was managed surgically. Six additional
women with persistent nonviable pregnancies/sacs had home
tests which showed a decrease in hCG from baseline to
follow-up. These cases probably could have been managed
expectantly at home, although they did receive a surgical
completion at the clinic at the follow-up appointment.
Unfortunately, the one woman with an ongoing pregnancy in
this study did not complete her pregnancy test at home. As
per protocol, on the morning of her follow-up (and prior to
clinical examination), she was asked to use the test at the
clinic. The ongoing pregnancy was identified as having a
higher hCG reading than at baseline by the pregnancy test
used at the clinic and then verified by provider exam. No
participants who had a decrease in hCG shown on the test
from baseline to follow-up were later identified to have anongoing pregnancy. We calculated sensitivity and specificity
of the test detecting continuing pregnancy versus all other
outcomes and found that the sensitivity and the specificity of
the semi-quantitative pregnancy test were high [100.0%
(n=1/1) and 97.0% (n=321/331), respectively] (Table 3).
Approximately two thirds of clinical trial participants
(58.1%, n=190) correctly determined their need to return to
the clinic based on the home test reading being the same or
higher than their baseline level. Most (91.1%, n=316) found
the home test to be “very easy” or “easy” to use. In addition,
most (89.5%, n=306) found that the information provided
by the provider ahead of time helped them to use and
understand the test at home.
Results from the user comprehension survey are shown
on Table 4. The average age of survey respondents was 27
years, and more than two thirds (70.2%, n=113/161) had
less than a college degree. Most (92.1%, n=174/189) were
able to read the pregnancy test accurately. Women with less
than a college degree were slightly less successful than those
with a college degree or higher at correctly reading the test
(88.5%, n=100/113), and all participants with a college
degree or higher read the test correctly. Among those who
accurately read the test, close to three quarters (73.6%,
n=128/174) correctly interpreted the numerical value of the
test. This finding differed by education level: 66.0%
(n=66/100) of women without a college degree and 85.4%
(n=41/48) of women with a college degree or higher
correctly read and interpreted the threshold hCG level ofT
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for clinic-based follow-up. Approximately three quarters of
the survey respondents (77.2%, n=132/171) thought that the
instruction sheet helped them to interpret the pregnancy test
results, and nearly sixty percent (59.3%, n=112/189)
reported that the pregnancy test was “very easy” or “easy”
to use. Four of every five women (80.7%, n=138/171)
reported that they could use the test by themselves in the
future to determine pregnancy status.
4. Discussion
These results demonstrate that this semi-quantitative
urine hCG test can be used as a pragmatic indicator of the
need for medical abortion clinical follow-up and, based on
ease of use, could successfully replace routine mandatory
in-person follow-up visits. The vast majority of tests used
by participants in the clinical study accurately indicated
whether or not each woman needed to return to the clinic
for further care. Additionally, the one ongoing pregnancy
in the study was successfully identified with the urine test
when used at the follow-up visit. However, the program-
matic applications of the test still need development. While
most women participating in both the clinical trial and the
user comprehension survey correctly read their home test,
more than half of the participants in the clinical trial
reported that they felt that clinic-based follow-up was
needed. Upon further exploration with the study team, we
have two hypotheses for why this may have occurred.
Certainly, we could focus future efforts on improving
counseling on how to interpret the test and by simplifying
the information sheet given to women. It is also
conceivable that the very nature of this clinical study,
instructing all women to return for clinic-based follow-up,
led to misunderstanding as to how to answer this question
and/or whether or not clinic follow-up was necessary.
Using this semi-quantitative pregnancy test as an
alternative to standard follow-up procedures could sub-
stantially reduce the proportion of medical abortion clients
needing to return to the clinic. In our study, 97.5% of
women with successful medical abortions did not need
additional care and could have avoided an unnecessary
follow-up visit, saving time and money for both women
and the health care system. Combining the home
pregnancy test with a list of clinical signs and symptoms,
such as “feeling pregnant” and “bleeding for at least one
day,” for women to use may further improve the ability for
women to self-assess their need to return to the clinic
[1,2,4]. Eliminating the need for an extra visit might be
especially beneficial for women living in rural areas who
travel great distances to access abortion care, as well as for
women living in places where abortion is highly
stigmatized and/or illegal. To that end, service delivery
with home pregnancy tests as a potential replacement to
in-person follow-up should be further explored for
implementation in health systems globally.The switch to home-based outcome assessment would
also signal a task shifting in health care in the United
States and elsewhere. Abortion follow-up would no longer
be focused on the skills of the clinician, but rather on the
woman herself, with minimal assistance via phone or e-
mail by a nurse or midlevel “facilitator.” While physicians
are legally required to administer abortion drugs in many
states, the rest of the process has long excluded
physicians as mandatory participants. The introduction
of home-based follow-up would push the shift in health
care one step further, reducing the participation of any
clinician, including midlevel clinicians, in the abortion
process. For many clinics, this would ease the burden on
staff and reduce overall costs to both the clinic and
women. For some facilities, where a charge for a follow-
up visit is integral to medical abortion care, there is the
potential for reduced revenue for any given procedure if
follow-up is conducted from home. However, revenue
from such visits is often minimal, and the fact that many
women will not return to clinic for follow-up will
improve clinic/appointment availability for new clients,
thus actually enhancing revenues (since new visits are
better reimbursed) and improving overall access to service
and care.
These new data provide strong evidence that semi-
quantitative home pregnancy tests could be highly effective
in identifying ongoing pregnancy and the need to return for
further care. Next steps should include further development
of education and counseling materials so that women can
better understand the clinical implications of their home test
result and have more confidence in their interpretation of
the test. Establishing a phone-in or online protocol for
women to discuss the test results with a clinician and/or
providing a list of signs and symptoms for self-evaluation
may also be important.Acknowledgments
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